|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron diseaseDal Bello-Haas V, Florence JM, Krivickas LS SummaryTherapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron diseaseMuscle weakness is very common in people with amyotrophic lateral sclerosis (ALS). A weak muscle can be damaged if overworked, because it is already functioning close to its maximal limits. As a result of this, exercise programs for people with ALS may be discouraged. However, if a person with ALS is not active, deconditioning and disuse weakness occurs, superimposed on the weakness caused by the ALS itself. If the reduced level of activity persists, many organ systems can be affected and a person with ALS can develop further deconditioning, muscle and joint tightness which cause contractures and pain. All these make performing daily activities more difficult. This review found only two randomised studies of exercise in people with ALS. The studies were too small to determine to what extent exercise for people with ALS is beneficial or whether exercise is harmful. More research is needed. This is a Cochrane review abstract and plain language summary, prepared
and maintained by The Cochrane Collaboration, currently published in
The Cochrane Database of Systematic Reviews 2010 Issue 7, Copyright ©
2010 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd..
The full text of the review is available in The
Cochrane Library (ISSN 1464-780X). Editorial Group: Neuromuscular Disease Group This version first published online: April 16. 2008 AbstractBackgroundDespite the high incidence of muscle weakness in individuals with amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND), the effects of exercise in this population are not well understood. ObjectivesThe objective was to systematically review randomised and quasi-randomised studies of exercise for people with ALS or MND. Search strategyWe searched the Cochrane Neuromuscular Disease Group Trials Register, EMBASE (January 1980 to August 2007), LILACS (January 1982 to August 2007), MEDLINE (January 1966 to August 2007), Cochrane Central Register of Controlled Trials (CENTRAL), PEDro (January 1980 to August 2007), AMED (January 1985 to August 2007), HealthSTAR (January 1975 to August 2007), CINAHL (January 1982 to August 2007). We also searched Dissertation Abstracts, inspected the reference lists of all papers selected for review and contacted the authors with expertise in the field. Selection criteriaWe included randomised or quasi-randomised controlled trials of people with a diagnosis of definite, probable, probable with laboratory support, or possible amyotrophic lateral sclerosis, as defined by the El Escorial criteria. We included progressive resistance or strengthening exercise and endurance or aerobic exercise. The control condition was no exercise or standard rehabilitation management. Our primary outcome measure was improvement in functional ability, decrease in disability or reduction in rate of decline as measured by a validated outcome tool at three months. Our secondary outcome measures were improvement in psychological status or quality of life, decrease in fatigue, increase in, or reduction in rate of decline of muscle strength (strengthening or resistance studies), increase in, or reduction in rate of decline of aerobic endurance (aerobic or endurance studies) at three months and frequency of adverse effects. Data collection and analysisTwo review authors independently assessed trial quality and extracted the data. The authors of the papers were contacted to obtain information not available in the published articles. Main resultsWe identified two randomised controlled trials that met our inclusion criteria. The first examined the effects of a twice-daily exercise program of moderate load, endurance exercise versus "usual activities" in 25 people with ALS. The second examined the effects of thrice weekly moderate load and moderate intensity resistance exercises compared to usual care (stretching exercises) in 27 people with ALS. After three months, when the results of the two trials were combined, there was a significant weighted mean improvement in the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) measure of function in the exercise compared with the control groups (3.21, 95% confidence interval 0.46 to 5.96) in favour of the exercise group. No statistically significant differences in quality of life, fatigue or muscle strength were found. Authors' conclusionsThe only studies detected were too small to determine to what extent strengthening exercises for people with ALS are beneficial, or whether exercise is harmful. There is a complete lack of randomised or quasi-randomised clinical trials examining aerobic exercise in this population. More research is needed. |